Lisa Yen
@lisayentwin
Followers
769
Following
6K
Media
226
Statuses
1K
Director of Programs/Outreach, Neuroendocrine Cancer Foundation @NCFCancer (formerly @LACNETS); NP Hospitalist turned NET caregiver+pt advocate. Tweets mine
Los Angeles, CA
Joined May 2012
Calling ANY HCPs who sees #NET + patients + caregivers to contribute to global research 👉Take this important global #SCAN2025 survey: https://t.co/d1TerwXz1s 👉Spread the word! @NANETS1 @OncBrothers @UGrewalMD @AmanChauhanMD @OncoThor @marklewismd @PamelaKunzMD @HalletJulie
incalliance.org
In 2025, INCA will launch SCAN 2 to measure the changes in the global access to diagnostics, treatments and care for neuroendocrine tumor patients.
Patients, caregivers, and healthcare professionals — your voice matters. Take part in the Survey of Challenges in Access for Diagnostics and Treatment for NET Patients (SCAN) 2025, available in 15 languages. 🗓️ Don’t miss your chance to make an impact — the survey closes
0
7
11
New Research Update: Promising Results for Alpha Therapy in NETs October 8, 2025 — Sanofi announced that its investigational treatment AlphaMedix™ (²¹²Pb-DOTAMTATE) met all primary goals in a phase 2 clinical trial, showing meaningful benefits for patients with
1
6
8
This is a must watch webinar! Super⭐️ @UGrewalMD will explain the rapidly evolving PRRT/RLT landscape in a patient-friendly way. Monday Sept 22nd at 3:30pm PT/6:30pm ET. Register here:
ncf.net
Very excited for this upcoming webinar with @NCFCancer @lisayentwin on Alpha Radioligand Therapy and other things PRRT next week. Looking forward to interacting with patients and caregivers and answering questions regarding RLT and more. Link to register-
0
2
5
It is with deep sadness that we share the passing of Dr. Richard R.P. Warner, who left us on June 15, 2025 in Denver, Colorado at the age of 97. A visionary physician and researcher, Dr. Warner founded the Carcinoid Cancer Foundation in 1968. His tireless work has touched
0
2
8
Tune in today at 7:30 am Pacific to watch our biggest event of the year: the 2025 Annual Patient Conference. This year, the event features 19 experts! ▶️▶️▶️ Watch at https://t.co/ko95p5uEV5
0
0
3
Join us for this Saturday's VIRTUAL conference, a unique opportunity to hear from 22 NET experts from across No America! @HalletJulie @DrCNClarke @AGangiMD @PamelaKunzMD @OncoThor @AmanChauhanMD @TheRealDoctorOs @DanengLi @DrHendifar @NadineMallak @ErikMittraMD
The Neuroendocrine Cancer Foundation's virtual annual conference is coming up! ➡️➡️Register now at https://t.co/ko95p5uEV5
@CarcinoidNETs @NANETS1 @HealingNET1 @netcancerday @CureNETs
0
2
5
Thanks @drjunaidarsh for hosting and moderating a fantastic event. Thanks to our speakers @sonbol_bassam @PamelaKunzMD @helops79 Dr Gaugs Singh, Dr Holly Thompson, and Dr Gregory Woodhead!
Last weekend, NCF hosted a Regional NET Patient Educational Event in Tucson. 75 NET community members gathered for an afternoon dedicated to learning, connection and hope. Read more at https://t.co/bnXWGklaJe
0
1
7
Thanks @drjunaidarsh for hosting amazing @NANETS1 and @NCFCancer educational conferences! Appreciate all your thoughtfulness, hard work and dedication. It was such a pleasure collaborating with you & getting to know you. Let’s keep fighting this fight together!
0
0
10
Fantastic news for the NET patient community!
Breaking news: The U.S. FDA approved Cabozantinib (@ExelixisInc) for patients 12 and older with previously treated, advanced #NeuroendocrineTumors. For details, please visit https://t.co/iwiAXSOuzv. Watch our interviews with Dr. Jennifer Chan on the #CABINET results:
0
2
5
➡️Register at https://t.co/x2QFMiQZGz Learn from internationally-renowned neuroendocrine cancer expert Dr. Edward Wolin in a discussion on the latest in neuroendocrine tumor treatments and understanding how to sequence them. Dr. Wolin has pioneered many of the NET treatments,
0
0
6
#ENETS2025 - Attention industry & researchers considering global trials: consider opening sites in Latin America to increase diversity and improve access to treatments. Please meet Dra Monica Meneses @MoniquMeneses from @INCMNSZ in Mexico City @ENETS_ORG
@NANETS1 @CarcinoidNETs
0
1
16
I got to sit with the cool kids today! 💕
We are ready for the joint NANETS-ENETS session. Looking forward to some great talks! Day 3 of #ENETS25 is off to a good start! 🦓 🎗️@lisayentwin @helops79 @NANETS1 @ENETS_ORG
1
2
12
#enets2025 ENETS-INCA joint session @OncoThor on Meaningful involvement of pts in NEN research Meredith Cummins @NECancerAus on pts partnering 🌎 @TimonV on aligning researcher & pt priorities Simron Singh on improving global research 🔑Essential to partner w advocates
1
13
20
1
1
8
#enets2025 - @Ja_Capdevila presents the much anticipated results of ITM’s COMPETE study, the first prospective, randomized phase 3 study comparing PRRT with an active treatment (everolimus). Positive results & good tolerability suggest potential for 1L or 2L treatment GEPNETS
1
13
39
LACNETS, now Neuroendocrine Cancer Foundation @NCFCancer representing at #ENETS25. 1st stop = INCA table to greet fellow global pt advocates @netcancerday @CureNETs @NECancerAus @NCkanker @PheoPara @CarcinoidNETs @ENETS_ORG
0
5
14
New name, new look 👀 Same amazing people and high quality content! ❤️
We are pleased to announce the evolution of the LACNETS organization by introducing our new name: Neuroendocrine Cancer Foundation. This rebranding signifies the strides we have made in reaching more patients and caregivers, and also in offering more educational and support
1
3
20
What to do with carcinoid crisis? 🦓 A frequent concern for patients with #NETs having surgery We put together an international🌎🌍🌏 multidisciplinary expert consensus statement 📢 Now open for feedback! Sign-up here 🔗 https://t.co/PGIFqB2mzE 📆Open until March 3rd!
1
19
39